Use of isoproterenol during programmed ventricular stimulation in patients with coronary artery disease and nonsustained ventricular tachycardia

American Heart Journal
M NiebauerF Morady

Abstract

Twenty-three consecutive patients (20 men and 3 women) with coronary artery disease and nonsustained ventricular tachycardia (VT) in whom sustained VT was not inducible in a baseline electrophysiology test underwent repeated testing during isoproterenol infusion to determine the inducibility of sustained monomorphic VT. After the baseline study, each patient received a 2 to 4 microgram/min infusion of isoproterenol (mean 2.5 +/- 0.8 microgram/min). The sinus cycle length shortened by a mean of 29% +/- 9% and programmed stimulation was repeated. Nineteen patients had no inducible sustained, monomorphic VT, two patients had only inducible nonsustained VT, and two patients had ventricular fibrillation. Patients were followed up for 10 to 20 months (mean 14.4 +/- 2.9 months) and had no syncope, sustained monomorphic VT, or sudden death. Isoproterenol infusion during programmed stimulation in patients with coronary heart disease and nonsustained VT does not facilitate the induction of sustained monomorphic VT.

Citations

Apr 17, 2003·Intensive Care Medicine·Georg Delle KarthGottfried Heinz
Dec 3, 2005·International Journal of Cardiology·Beatrice Brembilla-PerrotHadj Belhakem
Jan 20, 2015·Interventional Medicine & Applied Science·Narendra KumarCarl Timmermans
Jun 9, 2016·Expert Review of Cardiovascular Therapy·Ammar M KilluSamuel J Asirvatham
Mar 3, 2020·Pacing and Clinical Electrophysiology : PACE·Yasutoshi ShinodaMasaki Ieda

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.